Sébastien Larivé

Noninvasive Diagnosis of Actionable Mutations by Deep Sequencing of Circulating Free DNA in Lung Cancer from Never-Smokers: A Proof-of-Concept Study from BioCAST/IFCT-1002

S. Couraud, Felipe Vaca‐Paniagua, Stéphanie Villar et al. · Clinical Cancer Research · 2014 · 211 citations

Medicine, Molecular Genetics, Oncology +17

Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies

D. Debieuvre, Olivier Molinier, L. Falchero et al. · The Lancet Regional Health - Europe · 2022 · 76 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

New insights into stage and prognosis in small cell lung cancer: an analysis of 968 cases

C. Dayen, D. Debieuvre, Olivier Molinier et al. · Journal of Thoracic Disease · 2017 · 30 citations · Full text

Medicine, Oncology, Cancer Epidemiology +13

Real-world efficacy of the dabrafenib-trametinib (D-T) combination in BRAF V600E-mutated metastatic non-small cell lung cancer (NSCLC): Results from the IFCT-2004 BLaDE cohort

Aurélie Swalduz, Michèle Beau‐Faller, David Planchard et al. · Lung Cancer · 2024 · 19 citations

Medicine, Oncology, Pharmacology +13

Real world data of efficacy and safety of erlotinib as first-line TKI treatment in EGFR mutation-positive advanced non-small cell lung cancer: Results from the EGFR-2013-CPHG study

Thibault Payen, Jean Trédaniel, L. Moreau et al. · Respiratory Medicine and Research · 2020 · 10 citations

Medicine, Oncology, Pharmacology +15